Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REGORAFENIB vs REMIFENTANIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REGORAFENIB vs REMIFENTANIL: Safety Overview

Metric REGORAFENIB REMIFENTANIL
Total FAERS Reports 9,441 2,733
Deaths Reported 1,869 210
Death Rate 19.8% 7.7%
Hospitalizations 3,363 995
Average Patient Age 62.2 yrs 50.3 yrs
% Female Patients 39.9% 48.2%
FDA Approval Date Jan 13, 2025 Jan 16, 2018
Manufacturer Bayer HealthCare Pharmaceuticals Inc. Fresenius Kabi USA, LLC
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription